Ondine Biomedical Inc. (AIM:OBI)
London
· Delayed Price · Currency is GBP · Price in GBX 8.90
+0.10 (1.14%)
May 13, 2025, 12:18 PM GMT+1
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 39.00 million as of May 13, 2025. Its market cap has increased by 212.75% in one year.
Market Cap
39.00M
Enterprise Value
38.50M
Revenue
944.68K
Ranking
n/a
PE Ratio
n/a
Stock Price
8.90
Market Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 39.00M, a decrease of -65.44%. That is a compound annual growth rate of -26.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 39.00M | 9.70% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.79B |
| GSK plc | 55.98B |
| Haleon | 36.67B |
| Smith & Nephew | 9.35B |
| ConvaTec Group | 5.26B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 1.95B |
| Genus | 1.39B |